The fight over abortion has long been framed as a political battle, but at its core, it is a matter of life and death — for both mothers and their unborn children. President Donald Trump’s decision to call for a study on the safety of abortion pills is a commonsense and necessary step in putting women’s health above abortion industry profits.
At Heartbeat International, we manage the Abortion Pill Rescue Network and are the world’s largest pregnancy help network. Every day, we hear firsthand stories from women who regret taking the abortion pill, with some experiencing physical complications and emotional distress. Many, if not most, of these women express being misled into believing that the abortion pill would be a quick and easy fix, only to find themselves alone, afraid, and suffering the consequences of an industry designed to prioritize profit over protection.
Scientific evidence has long shown that the abortion pill regimen, mifepristone followed by misoprostol, carries serious risks, including hemorrhaging, infection, and even death for women taking this chemical concoction. Studies indicate that chemical abortion has a complication rate four times higher than that of surgical abortion, yet instead of strengthening safeguards, the Food and Drug Administration eliminated them. Under the previous administration, even critical in-person medical oversight was removed, leaving women to face these dangers alone with less care. This wasn’t a decision based on science or health; it was a reckless move to expand abortion access at any cost, all at the behest of Big Abortion.
The abortion industry misrepresents these drugs as safe and effective, all while dismissing the very real stories of women harmed by them. But the facts tell a different story. By removing long-standing safeguards, the last administration opened the floodgates for dangerous, mail-order abortions that put more women in crisis situations with no support and no recourse. This is not progress; it’s a dereliction of duty when it comes to women’s health and safety.
Women deserve better. They deserve real, compassionate medical care, informed consent, and the opportunity to change their minds if they regret their decision. Thousands of women have sought abortion pill reversal, desperate to undo the effects of a decision they felt pressured into making. Their stories, stories the abortion industry refuses even to acknowledge, underscore the reality that the abortion pill is not the risk-free, consequence-free solution it is marketed to be.
ABORTION PILLS ENTAIL WORSE PAIN AND BLEEDING THAN SURGICAL ABORTION, STUDY FINDS
Trump’s willingness to take a hard look at these drugs stands in stark contrast to the blind deregulation we’ve seen in recent years. A rigorous, unbiased study must be done because women deserve to know the truth, and policymakers must have the courage to act in their best interest.
Public servants, elected and appointed, should be first concerned with protecting the public. This is especially true in protecting women from an industry that persistently and perniciously prioritizes its bottom line over the well-being of women facing an unintended pregnancy. Heartbeat International urges the Trump administration to restore the commonsense safeguards recklessly abandoned by the last administration and to ensure that every woman is given the care, support, and medical oversight she truly deserves.
Jor-El Godsey is president of Heartbeat International.
